Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-25-024462
Filing Date
2025-03-17
Accepted
2025-03-17 16:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 POS AM tm258946d1_posam.htm POS AM 337005
2 EXHIBIT23.1 tm258946d1_ex23-1.htm EX-23.1 2384
  Complete submission text file 0001104659-25-024462.txt   340493
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-284627 | Film No.: 25745083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)